GlassScriptPhysician profile
Shariq Shamim
NPI 1356657977
$18,171.91
in general payments reported to CMS, 2019-2025
36 companies · $563 in 2025
The $563 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,158 · 2020: $546 · 2021: $1,581 · 2022: $5,746 · 2023: $6,169 · 2024: $2,408 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,800 · Food and Beverage: $3,162 · Travel and Lodging: $1,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,800.00 |
| Food and Beverage | $3,161.78 |
| Travel and Lodging | $1,177.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $8,712.66 | 2019-2023 | Indigo System |
| Medtronic, INC. | $2,678.45 | 2021-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $2,022.54 | 2019-2024 | |
| Abiomed | $1,020.53 | 2019-2025 | Impella |
| Abbott Laboratories | $616.91 | 2022-2025 | Mitraclip, Amplatzer Amulet, Gallant |
| Angiodynamics, INC. | $446.73 | 2021-2024 | Auryon Laser System 100-120 Vac, Angiovac, Alphavac |
| Philips North America LLC | $342.51 | 2019-2024 | (Az7) Lasers |
| Inari Medical, INC. | $323.76 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $315.66 | 2021-2025 | |
| Medtronic Vascular, INC. | $192.40 | 2019-2020 | |
| Cardiovascular Systems INC. | $144.93 | 2019-2021 | |
| Biotronik INC. | $120.86 | 2022 | |
| Janssen Pharmaceuticals, INC | $114.88 | 2021 | |
| Novo Nordisk INC | $110.60 | 2022-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $108.65 | 2019-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $107.00 | 2025 | Nuvision Ice Catheter |
| Terumo Medical Corporation | $94.87 | 2022 | |
| Bard Peripheral Vascular, INC. | $89.20 | 2020 | |
| Edwards Lifesciences Corporation | $80.90 | 2025 | Pascal |
| E.R. Squibb & Sons, L.L.C. | $74.47 | 2019-2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $50.92 | 2021-2025 | Farxiga |
| Esperion Therapeutics, INC. | $46.75 | 2021-2025 | Nexletol |
| Amgen INC. | $44.59 | 2023 | Repatha |
| Alnylam Pharmaceuticals INC. | $36.61 | 2023-2024 | Onpattro |
| Chiesi USA, INC. | $35.02 | 2019 | |
| Resmed Corp | $34.40 | 2025 | |
| Asahi Intecc USA, INC. | $31.78 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.18 | 2021-2025 | Jardiance |
| Corcept Therapeutics | $25.00 | 2023 | Korlym |
| Amarin Pharma, INC. | $21.50 | 2019 | |
| Teleflex LLC | $20.37 | 2019 | |
| Scpharmaceuticals INC. | $18.59 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.01 | 2023 | |
| Kestra Medical Technology Services, INC. | $15.42 | 2024 | Assure Wcd |
| Daiichi Sankyo INC. | $12.76 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shariq Shamim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.